RareCan discuss the barriers to rare cancer research and the potential for doing things differently with PAWS-GIST patient director Jayne Bressington

Today our Vice Chair Jayne Bressington participated in the first of a series of RareCan discussions. In this video Jayne and Debbie Binner, Non-executive director of RareCan, discuss their personal experiences of PAWS-GIST and Ewing’s Sarcoma with Professor Andy Hall a Founder and Director of RareCan. Please watch & share this video By joining RareCan, […]

Continue reading

With just a short time to 1st December, we are excited see how many famous faces are involved in this year’s BIG GIVE video…

  What happens during the BIG GIVE Christmas Challenge? Donations made via GIST Cancer UK’s project page: between 12 noon on December 1st and 8th will be matched. This means that your donation will be doubled and have twice the impact! All you need to do is:  At 12 noon on 1st December make your donation […]

Continue reading

One donation, twice the impact! Your donation to GIST Cancer UK will be doubled in the BIG GIVE CHRISTMAS CHALLENGE!

We are very excited to have been selected to participate in the “Big Give Christmas Challenge 2020”, which is the UK’s largest matched funding campaign. Thank you “The Hospital Saturday Fund” for being our champion! Our fundraising project Supporting GIST Cancer patients through the Covid19 pandemic is aiming  to make up the shortfall in our […]

Continue reading

Join the 20:20 Challenge for GIST Cancer UK!

We have joined forces with 19 other less common cancer charities to create a unique & exciting 20-day challenge called the 20for20 Challenge to raise funds to make up the shortfall in our income due to the pandemic. Funds that are vital to enable us to continue with our work. The Covid-19 pandemic has led […]

Continue reading

GCUK PAWS-GIST funded research published in The Journal of Clinical Pathology

In 2017 GIST Cancer UK approved a research grant application for pathologist Dr Newton Wong to undertake next generation sequencing  (NGS) of wild-type GIST’s to identify therapeutic targets. Earlier this month (July 2020) – Dr Wong’s research paper “Next generation sequencing demonstrates the rarity of short kinase variants specific to quadruple wild type gastrointestinal stromal […]

Continue reading